Nursing Considerations for ICI-Related Myocarditis

Elisa Becze, BA, ELS, Editor


Before immunotherapies like immune checkpoint inhibitors (ICIs) became a cancer treatment option, myocarditis typically developed in the presence of infections, drug allergies, or autoimmune diseases. Activating the immune system with ICIs can also trigger autoimmune-like adverse events such as myocarditis, and although its incidence in patients with cancer is low, mortality is high.

View Article @

ONS Voice Articles

ONS's member magazine articles.

View All Voice Articles